Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects
about
The role of platelets in the recruitment of leukocytes during vascular diseaseHigh-maintenance-dose clopidogrel in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysisEffects of clopidogrel therapy on oxidative stress, inflammation, vascular function, and progenitor cells in stable coronary artery disease.Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia-reperfusion injury.Association between peak neutrophil count, clopidogrel loading dose, and left ventricular systolic function in patients with primary percutaneous coronary intervention.Clopidogrel, independent of the vascular P2Y12 receptor, improves arterial function in small mesenteric arteries from AngII-hypertensive rats.Oral clopidogrel improves cutaneous microvascular function through EDHF-dependent mechanisms in middle-aged humans.Reduced plasma adiponectin levels relative to oxidized low density lipoprotein and nitric oxide in coronary artery disease patients.Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac CatheterizationNitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances.Clopidogrel Improves Skin Microcirculatory Endothelial Function in Persons With Heightened Platelet Aggregation.Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention.Bivalirudin decreases NO bioavailability by vascular immobilization of myeloperoxidase.CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammationProdrugs in cardiovascular therapy.Clinical implications of platelet-vessel interaction.A retrospective review of clopidogrel as primary therapy for migraineurs with right to left shunt lesions.Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation.Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded study.Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridinesProtective effects of ginseng extracts and common anti-aggregant drugs on ischaemia-reperfusion injury.The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway.Targeting Select Cellular Stress Pathways to Prevent Hyperglycemia-Related Complications: Shifting the Paradigm.A literature review of antithrombotic and anticoagulating agents on sexual function.Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence.Clopidogrel application: beyond coronary artery disease.Effects of CYP2C19 and P2Y12 Gene Polymorphisms on Clinical Results of Patients Using Clopidogrel after Acute Ischemic Cerebrovascular Disease.The influence of clopidogrel on ischemia diagnosed by myocardial perfusion stress testing.Antiatherosclerotic potential of clopidogrel: antioxidant and anti-inflammatory approaches.Beneficial effects of clopidogrel on glycemic indices and oxidative stress in patients with type 2 diabetes.Efficacy and safety of cangrelor for patients with coronary artery disease: a meta-analysis of four randomized trials.No effect of clopidogrel activity or cessation on vascular function or markers of inflammation.Rates and predictors of 5-year survival in a national cohort of asymptomatic elderly patients undergoing carotid revascularization.Clopidogrel for the hot patient.eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment.Effect of clopidogrel on neointimal formation and inflammation in balloon-denuded and radiated hypercholesterolemic rabbit iliac arteries.Clopidogrel in a combined therapy with anticancer drugs-effect on tumor growth, metastasis, and treatment toxicity: Studies in animal models.Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy.Effects of clopidogrel on inflammatory cytokines and adhesion molecules in human endothelial cells: Role of nitric oxide mediating pleiotropic effects.The Effect of Clopidogrel on the Response to Ischemia Reperfusion.
P2860
Q26801407-11461ED8-6F4B-49CE-88B4-26E9AEA4AB97Q26996325-9D42835C-9012-4455-A6DD-BB6366C28BC2Q33715270-21548A4C-7204-4A3D-BF80-1DA1BF1D816CQ34027137-123346DF-076A-4AE1-8DA8-9851455F7E4FQ34039741-12355387-020D-4EFC-AFED-25E419AE71C0Q34705086-9D50D359-E635-43E8-AB7A-12E1E062E004Q34785100-54467FE5-329D-4DD5-B4C8-AB3EB3128C00Q35141900-22C22B07-DBA2-4323-AE78-2369CDEC470DQ35735264-A93912EE-5D0A-4AAF-A216-73C3323678C4Q35902581-A48986F0-EFEE-41EA-90F9-F146D991D62BQ36178772-F51E9AF5-592D-469D-AF18-A942B63ECAB5Q36216896-0DE4EFB3-75EE-4461-B2B1-7B009FE0CDDCQ36953866-405CB30C-B38C-4A4F-87FB-6DC6749387EEQ37138961-0E51DAAF-1D63-4129-BF24-DF3A6A6B7EF0Q37193597-77009ED8-0301-4675-8FC8-FFEAEFE47F94Q38070127-D6FE4FB0-26E9-4074-94BC-60E6D2A81442Q38207479-15985CA7-349B-4FD7-A3AA-E89BF2F871CDQ38412151-17377EDA-60F1-4050-8032-75981F00398CQ38675528-9B89F2B8-7BFC-4263-8FF8-182E955211DDQ38694069-D384E578-9BBE-4B04-A585-4CC940EE47F0Q38804326-4BF9ECBF-F182-497D-9A4D-1A67F8B95291Q38838327-934E9EFA-37CF-4003-B985-511E5497530BQ38846534-39C85180-ADB7-4F90-9650-4BD302CA91A0Q38928148-A5D62A03-604B-4384-8712-CF429CF3173AQ38990014-1017C49F-895C-485C-93CD-B432513C100FQ39932446-627A49DD-4073-4167-9E23-96770A214868Q40044394-245F694B-CAF1-42CE-89B8-3E7258686FB6Q40575675-136C2999-265F-4EAF-B9D9-39E1AF7C00E5Q41866032-827CF2F3-60BB-4EDE-A90D-F05408238E8DQ41912245-8F27F6B6-AEB3-47C6-BC63-3BB3EF8227E5Q41947293-D4A7E99E-7640-441F-8E62-D36522B54697Q42090585-A7976EF7-2487-4572-9267-9595120D0715Q42697095-DB3CF284-84C7-41B9-9BEC-3B9433D49083Q42725474-380052CF-DC72-4A85-AF64-391FA44378F3Q43248056-4785839F-A99B-448A-8BE8-98F98B63CE80Q46724290-5954965A-43CA-4B0C-9298-F827865C3252Q47094540-CA271DCC-AA74-43DB-BDAA-025ADEE1A91DQ48214315-0704FE28-8D31-4345-981E-6283828C0596Q48329910-1812DE69-0A50-4D93-AE69-2A7FAA10AFB9Q50598217-0BB0DCD3-57D0-434E-8AFE-CCE2B17665B5
P2860
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clopidogrel improves systemic ...... t and antiinflammatory effects
@ast
Clopidogrel improves systemic ...... t and antiinflammatory effects
@en
Clopidogrel improves systemic ...... t and antiinflammatory effects
@nl
type
label
Clopidogrel improves systemic ...... t and antiinflammatory effects
@ast
Clopidogrel improves systemic ...... t and antiinflammatory effects
@en
Clopidogrel improves systemic ...... t and antiinflammatory effects
@nl
prefLabel
Clopidogrel improves systemic ...... t and antiinflammatory effects
@ast
Clopidogrel improves systemic ...... t and antiinflammatory effects
@en
Clopidogrel improves systemic ...... t and antiinflammatory effects
@nl
P2093
P921
P1476
Clopidogrel improves systemic ...... t and antiinflammatory effects
@en
P2093
Edzard Schwedhelm
Karsten Sydow
Manuela Karstens
Michelle Ortak
Peter Tschentscher
Rainer Böger
Stephan Baldus
Thomas Heitzer
Thomas Meinertz
Volker Rudolph
P304
P356
10.1161/01.ATV.0000225288.74170.DC
P407
P577
2006-07-01T00:00:00Z